Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Clinical trial NCT01485614 · COMPLETED
Trial details
- NCT number
- NCT01485614
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-10
- Primary completion
- 2019-10-09
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.